Abstract:Background: Protein theranostics integrate both diagnostic and treatment functions on a single disease-targeting protein. However, the preparation of these multimodal agents remains a major challenge. Ideally, conventional recombinant proteins should be used as starting materials for modification with the desired detection and therapeutic functionalities, but simple chemical strategies that allow the introduction of two different modifications into a protein in a site-specific manner are not currently available. We recently discovered two highly efficient peptide ligases, namely butelase-1 and VyPAL2. Although both ligate at asparaginyl peptide bonds, these two enzymes are bio-orthogonal with distinguishable substrate specificities, which can be exploited to introduce distinct modifications onto a protein.Methods: We quantified substrate specificity differences between butelase-1 and VyPAL2, which provide orthogonality for a tandem ligation method for protein dual modifications. Recombinant proteins or synthetic peptides engineered with the preferred recognition motifs of butelase-1 and VyPAL2 at their respective C- and N-terminal ends could be modified consecutively by the action of the two ligases.Results: Using this method, we modified an EGFR-targeting affibody with a fluorescein tag and a mitochondrion-lytic peptide at its respective N- and C-terminal ends. The dual-labeled protein was found to be a selective bioimaging and cytotoxic agent for EGFR-positive A431 cancer cells. In addition, the method was used to prepare a cyclic form of the affibody conjugated with doxorubicin. Both modified affibodies showed increased cytotoxicity to A431 cells by 10- and 100-fold compared to unconjugated doxorubicin and the free peptide, respectively.Conclusion: Bio-orthogonal tandem ligation using two asparaginyl peptide ligases with differential substrate specificities is a straightforward approach for the preparation of multifunctional protein biologics as potential theranostics.

OaAEP1-mediated PNA-protein conjugation enables erasable imaging of membrane protein

OaAEP1-mediated PNA-protein Conjugation Enables Erasable Imaging of Membrane Proteins

Ligand-free Palladium-Mediated Site-Specific Protein Labeling Inside Gram-Negative Bacterial Pathogens.

OaAEP1-Mediated Enzymatic Synthesis and Immobilization of Polymerized Protein for Single-Molecule Force Spectroscopy

Unveiling the Promise of Peptide Nucleic Acids as Functional Linkers for Riboglow RNA Imaging Platform

One-step Asparaginyl Endopeptidase (Oaaep1)-Based Protein Immobilization for Single-Molecule Force Spectroscopy.

Genetically Encoding an Electrophilic Amino Acid for Protein Stapling and Covalent Binding to Native Receptors

PNA-dependent Gene Chemistry: Stable Coupling of Peptides and Oligonucleotides to Plasmid DNA.

Directed evolution of a probe ligase with activity in the secretory pathway and application to imaging intercellular protein-protein interactions

Single-nucleotide-specific PNA-peptide ligation on synthetic and PCR DNA templates

Enzymatic Protein Immobilization for Nanobody Array

Engineering protein theranostics using bio-orthogonal asparaginyl peptide ligases

Nucleic Acid Covalent Tags

Enzymatic Protein Immobilization on Amino-Functionalized Nanoparticles

Phosphorylated Lipid-Conjugated Oligonucleotide Selectively Anchors on Cell Membranes with High Alkaline Phosphatase Expression

Enzymatic Protein-Protein Conjugation Through Internal Site Verified at the Single-Molecule Level

NTA-Functionalized Poly(L-lysine)-g-Poly(Ethylene Glycol): A Polymeric Interface for Binding and Studying 6 His-tagged Proteins

One-Step Protein Conjugation to Upconversion Nanoparticles.

Controlled Assembly of AIEgens Based on a Super-Quadruplex Scaffold for Detection of Plasma Membrane Proteins

Small Molecule-Linked Programmable DNA for Washing-Free Imaging of Cell Surface Biomarkers.

Selective and Nongenetic Peroxidase Tag of Membrane Protein: a Nucleic Acid Tool for Proximity Labeling